Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Myelitis, Transverse × ravulizumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Recurrence 1 Optic Neuritis 1 Neuromyelitis Optica 1 Myelitis, Transverse 1 Myasthenia Gravis 1 Demyelinating Diseases 1

Interventions

ublituximab 1 ravulizumab 1 eculizumab 1 Sugars 1 Rituximab 1 OM 89 1 Mitoxantrone 1 LFB-R603 1 Interferon beta-1a 1 4-Aminopyridine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04201262 2025-10-14

An Efficacy and Safety Study of Ravulizumab in Adult Participants With NMOSD

Alexion Pharmaceuticals, Inc.

Phase 3 Completed

58 enrolled 19 charts

Demyelinating Diseases, Myelitis, Transverse, Neuromyelitis Optica, Optic Neuritis, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡